820 related articles for article (PubMed ID: 29150141)
1. Hepatocellular carcinoma in the era of immunotherapy.
Sim HW; Knox J
Curr Probl Cancer; 2018; 42(1):40-48. PubMed ID: 29150141
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of the advanced HCC: A second revolution by using immunotherapy].
Fartoux L; Rosmorduc O
Biol Aujourdhui; 2018; 212(3-4):85-87. PubMed ID: 30973137
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma: Mechanisms of progression and immunotherapy.
Jiang Y; Han QJ; Zhang J
World J Gastroenterol; 2019 Jul; 25(25):3151-3167. PubMed ID: 31333308
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy for hepatocellular carcinoma patients: is it ready for prime time?
Obeid JM; Kunk PR; Zaydfudim VM; Bullock TN; Slingluff CL; Rahma OE
Cancer Immunol Immunother; 2018 Feb; 67(2):161-174. PubMed ID: 29052780
[TBL] [Abstract][Full Text] [Related]
5. How we approach it: treatment options for hepatocellular carcinoma.
Hernaez R; El-Serag HB
Am J Gastroenterol; 2018 Jun; 113(6):791-794. PubMed ID: 29713029
[No Abstract] [Full Text] [Related]
6. Immunotherapy of Hepatocellular Carcinoma.
Heinrich B; Czauderna C; Marquardt JU
Oncol Res Treat; 2018; 41(5):292-297. PubMed ID: 29705790
[TBL] [Abstract][Full Text] [Related]
7. Advanced Hepatocellular Cancer: the Current State of Future Research.
Connell LC; Harding JJ; Abou-Alfa GK
Curr Treat Options Oncol; 2016 Aug; 17(8):43. PubMed ID: 27344158
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy for hepatocellular carcinoma: Current and future.
Johnston MP; Khakoo SI
World J Gastroenterol; 2019 Jun; 25(24):2977-2989. PubMed ID: 31293335
[TBL] [Abstract][Full Text] [Related]
9. Targeting Tumor-Associated Antigens in Hepatocellular Carcinoma for Immunotherapy: Past Pitfalls and Future Strategies.
Lu L; Jiang J; Zhan M; Zhang H; Wang QT; Sun SN; Guo XK; Yin H; Wei Y; Li SY; Liu JO; Li Y; He YW
Hepatology; 2021 Feb; 73(2):821-832. PubMed ID: 32767586
[No Abstract] [Full Text] [Related]
10. Potentiality of immunotherapy against hepatocellular carcinoma.
Tsuchiya N; Sawada Y; Endo I; Uemura Y; Nakatsura T
World J Gastroenterol; 2015 Sep; 21(36):10314-26. PubMed ID: 26420958
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy for hepatocellular carcinoma.
Li S; Yang F; Ren X
Drug Discov Ther; 2015 Oct; 9(5):363-71. PubMed ID: 26632545
[TBL] [Abstract][Full Text] [Related]
12. [Hepatocellular carcinoma - from immunobiology to immunotherapy].
Flecken T; Schmidt N; Spangenberg HC; Thimme R
Z Gastroenterol; 2012 Jan; 50(1):47-56. PubMed ID: 22222798
[TBL] [Abstract][Full Text] [Related]
13. Shifting paradigms in the systemic management of hepatocellular carcinoma.
Pinato DJ
Lancet Gastroenterol Hepatol; 2020 Oct; 5(10):883-885. PubMed ID: 32941832
[No Abstract] [Full Text] [Related]
14. Potential of immunotherapy for hepatocellular carcinoma.
Breous E; Thimme R
J Hepatol; 2011 Apr; 54(4):830-4. PubMed ID: 21145836
[TBL] [Abstract][Full Text] [Related]
15. TATI modality: A new perspective on the treatment of advanced hepatocellular carcinoma.
Li X; Liang P; Ye X
J Cancer Res Ther; 2020 Sep; 16(5):957-959. PubMed ID: 33004734
[No Abstract] [Full Text] [Related]
16. Immunotherapy in hepatocellular carcinoma.
Buonaguro L; Mauriello A; Cavalluzzo B; Petrizzo A; Tagliamonte M
Ann Hepatol; 2019; 18(2):291-297. PubMed ID: 31047849
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapeutic treatments in hepatocellular carcinoma; achievements, challenges and future prospects.
Roudi R; D'Angelo A; Sirico M; Sobhani N
Int Immunopharmacol; 2021 Dec; 101(Pt A):108322. PubMed ID: 34735916
[TBL] [Abstract][Full Text] [Related]
18. Combinatorial immunotherapy strategies for hepatocellular carcinoma.
Tagliamonte M; Petrizzo A; Tornesello ML; Ciliberto G; Buonaguro FM; Buonaguro L
Curr Opin Immunol; 2016 Apr; 39():103-13. PubMed ID: 26851637
[TBL] [Abstract][Full Text] [Related]
19. Cancer-associated fibroblasts induce immunotherapy resistance in hepatocellular carcinoma animal model.
Yu L; Liu Q; Huo J; Wei F; Guo W
Cell Mol Biol (Noisy-le-grand); 2020 May; 66(2):36-40. PubMed ID: 32415924
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular Carcinoma: New Developments.
Ganesan P; Kulik LM
Clin Liver Dis; 2023 Feb; 27(1):85-102. PubMed ID: 36400469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
